Ozempic and Wegovy linked to a lower risk of cannabis use disorder
An analysis of almost 700,000 people with type 2 diabetes or obesity found that those prescribed Ozempic or Wegovy were about half as likely to develop cannabis use disorder as those taking other medications
Source: New Scientist - Health - Category: Consumer Health News Source Type: research
More News: Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Health | Obesity